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    （1） Many new drings have been discQvered lately and rriost clinicians have beeh very
busy in conducting clinical studies with them． Therefore， cases of experiments aY each in－
 stitution’ have decreased． ThuS，’ it see．ms meaningless to collect mqny clinical results which
 have been obtained by different皿ethods of study． 耳or tha㌻reason， the田ethodS gf study
 were tinified beforehand and cooperative clinical studies’ with cephaloglycin have been made
 at．fourμniversities． As this was the first trial of cooperative clinical＄旗dies，．．the expec亡ed
＊微生物学教憲
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putpose scas not attained because of insutlicient contact among researchers． But it seeins
that this trial will be helpful to further cooperative clini6al study．
  （2） One gram of cephaloglycin per day was given to patients of acute uncomplicated
cystitis for three days and it was effective in twenty－three cases out of twenty－five （92％）．
This result was gained by judging its ethciency irom syrnptorns， urinalysis and culture study．
When its efficiency．was judged from symptoms and urine findings， it was effective in fourty－
five cases out of fifty－three （85％）．
  （3）’ A comparative study ・was made between rernedial results of a group of patients who
had been given cephaloglycin from beginning to healing一， and that of another one of patients
who had been given cephaloglycin until their conditions of illness were less serious and then














        実 験 方 法





 2．群   別
 薬剤の投与方法によってつぎの2群に大別した．
 （1）CEG群
   初診時より治癒するまでCEGを投与するもの。
 （2）CEG十SN群
   はじあCEGを投与し，回状軽減後はSN投
   与に切替えるもの．
 なお群別ははじめから無作為におこなわれた．
 3．薬剤投与方法



























検 討 項 目 不 変 改 三
戸 覚 症 状 （排尿痛，頻度） 2 上









































































 Table 4 CEG群とCEG＋SN群との比較一1
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項  目 症例数 消失．改善．?ﾊ
症  状 53









                    コ           初診時   31］後判定    7日後判定
  一ご扉一’一一一∵τ：’i 外一じEδ．’州
Fig．1CEG群の経過（二者判定：12例）
㌶！一驚＼
  凝診詩   3日後判定    7日後判定  ～e［ヨ後判定
   トーで岳．「一一37ヂー→ト耐1ゾ→
Fig．2CEG＋SN群の経過（二者判定：12例）
     1|養所見














































   12し．
園  ij’





































84 西浦・ほか：Cephaloglycin・共同臨床実験  ’
 投与後の尿路感染菌28株に対するCEGのMICは
Table 8のごとく，感性株と耐性株の2峰性分布を
  Table 8 尿路感染菌の菌種とCEG．のMIC
      （投与後）
CEGのMIC（28株）菌   種
株数
1．563．136．2512．5 25  50 50＜





Strept． faeti． 1 7i［ 3
StrePt．        21i 2   haemoly．
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